[{"id":"ruth-plummer","kind":"person","name":"Ruth Plummer","route":"/people/ruth-plummer/","commit":"0bdbdae6c6","date":"2026-09-09","author":"Jude Gomila","message":"Editing pass: every TL;DR and summary stands alone","file":"src/data/people/europe.ts","type":"changed","fields":[{"field":"tldr","before":"\"Early-phase trialist who ran the first-in-human study of a PARP inhibitor.\"","after":"\"Ruth Plummer is an early-phase trialist who ran the first-in-human study of a PARP inhibitor.\""}]},{"id":"ruth-plummer","kind":"person","name":"Ruth Plummer","route":"/people/ruth-plummer/","commit":"5544163530","date":"2026-09-08","author":"Jude Gomila","message":"People: leading clinicians and scientists at European institutions","file":"src/data/people/europe.ts","type":"added","fields":[{"field":"id"},{"field":"name"},{"field":"role"},{"field":"institutionId"},{"field":"institutions"},{"field":"specialisms"},{"field":"tldr"},{"field":"summary"},{"field":"profiles"},{"field":"drugs"},{"field":"targets"},{"field":"papers"}]}]